Sylvie Friard
Hôpital Foch · 89 works · 2,116 citations · h-index 18
Top works
- Baseline results of the Depiscan study: A French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR)
- Intestinal Akkermansia muciniphila predicts clinical response to PD-1 blockade in patients with advanced non-small-cell lung cancer
- Custom scoring based on ecological topology of gut microbiota associated with cancer immunotherapy outcome
- Detection of Pelvic Vein Thrombosis by Magnetic Resonance Angiography in Patients With Acute Pulmonary Embolism and Normal Lower Limb Compression Ultrasonography
- Crizotinib Associated with Ground-Glass Opacity Predominant Pattern Interstitial Lung Disease: A Retrospective Observational Cohort Study with a Systematic Literature Review
- Resistance mechanisms to osimertinib in EGFR-mutated advanced non-small-cell lung cancer: A multicentric retrospective French study
- Lung Cancer in Patients with HIV Infection and Review of the Literature
- Consolidation nivolumab and ipilimumab versus observation in limited-disease small-cell lung cancer after chemo-radiotherapy – results from the randomised phase II ETOP/IFCT 4-12 STIMULI trial
- PREDICTIVE VALUE OF CYTOMEGALOVIRUS DNA DETECTION BY POLYMERASE CHAIN REACTION IN BLOOD AND BRONCHOALVEOLAR LAVAGE IN LUNG TRANSPLANT PATIENTS1
- Cost-effectiveness of three strategies for second-line erlotinib initiation in nonsmall-cell lung cancer: the ERMETIC study part 3
- IFCT-GFPC-0701 MAPS trial, a multicenter randomized phase III trial of pemetrexed-cisplatin with or without bevacizumab in patients with malignant pleural mesothelioma (MPM).
- Efficacy and safety of gefitinib during pregnancy: Case report and literature review
- Cost-effectiveness ofKRAS,EGFRandALKtesting for decision making in advanced nonsmall cell lung carcinoma: the French IFCT-PREDICT.amm study
- Lorlatinib – Induced pulmonary arterial hypertension
- Protocole IFCT-0302 : essai randomisé de deux schémas de surveillance dans les cancers bronchiques non à petites cellules complètement réséqués
- Durable responses to immunotherapy of non-small cell lung cancers harboring MET exon-14–skipping mutation: A series of 6 cases
- Anti-tumour effect of low molecular weight heparin in localised lung cancer: a phase III clinical trial
- Efficacy of next treatment received after nivolumab progression in patients with advanced nonsmall cell lung cancer
- Histomolecular Resistance Mechanisms to First-Line Osimertinib in EGFR-Mutated Advanced Non-Small Cell Lung Cancer: A Multicentric Retrospective French Study
- Real-life experience of ceritinib in crizotinib-pretreatedALK+advanced non-small cell lung cancer patients